8 ASX 200 shares with renewed buy ratings this week

Brokers retained a positive view on CSL, GQG Partners, ANZ, and other shares this week. 

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) shares are down 0.4% to 8,614.8 points on Thursday.

Meanwhile, brokers have indicated continuing confidence in several ASX 200 shares with refreshed buy calls this week.

Here are some examples.

A young woman smiling and looking happy, indicating a positive share price movement on the ASX market.

Image source: Getty Images

CSL Ltd (ASX: CSL)

The CSL share price is $107.34, up 4.3% today.

The ASX 200's largest healthcare share is having a strong week despite no price-sensitive announcements.

Since last Friday's close, CSL shares have spiked 9.6% while the S&P/ASX 200 Health Care Index (ASX: XHJ) has lifted just 3.6%.

CSL shares have fallen 63% over two years, but perhaps a turnaround is afoot?

UBS reiterated its buy rating on CSL shares on Tuesday.

However, the broker lowered its target price from $175 to $158.

This still implies potential capital gains of 47% ahead.

South32 Ltd (ASX: S32)

The South32 share price is $4.35, down 2.9% today.

Over the past six months, this ASX 200 mining share has risen 27%.

Citi reaffirmed its buy rating on South32 shares on Tuesday.

The broker increased its 12-month price target from $5.40 to $6.10.

This suggests a potential 40% upside ahead.

Flight Centre Travel Group Ltd (ASX: FLT)

The Flight Centre share price is $10.97, down 3.1%.

This ASX 200 travel share has fallen 26% over six months.

But UBS is confident of a turnaround, reiterating its buy rating this week.

The broker has a $14.50 target on the ASX 200 consumer discretionary share.

This suggests a 32% upside from here.

ANZ Group Holdings Ltd (ASX: ANZ)

The ANZ share price is $34.02, down 1.6% today.

This ASX 200 bank share has fallen 5.3% over the past month.

Citi reiterated its buy rating on ANZ shares with a price target of $39.25 on Tuesday.

This implies potential capital gains of 15% ahead.

GQG Partners Inc (ASX: GQG)

The GQG Partners share price is $1.46, up 0.3% today.

Over the past six months, this ASX 200 financial share has fallen 17%.

Morgans renewed its accumulate rating on GQG Partners shares yesterday.

The broker lowered its 12-month price target from $2.03 to $1.64.

This suggests a potential 12% upside ahead.

Morgans commented:

While the near-term operating environment remains difficult, we continue to see long-term value in the GQG franchise, trading at ~9x FY1 PE with a ~10% dividend yield.

Life360 Inc (ASX: 360)

The Life360 share price is $21.21, down 1.6% today.

Over the past month, this ASX tech share has recovered 5.6%.

Life360 has lost 33% of its valuation over the past 12 months.

Citi reaffirmed its buy rating on Life360 shares on Tuesday.

The broker modified its target from $32.10 to $28.25, suggesting a potential 33% increase from here.

SRG Global Ltd (ASX: SRG)

The SRG Global share price is $3.69, down 3.5% today.

This ASX 200 industrials share has ascended 32% over six months.

Morgans renewed its buy call on SRG Global shares this week.

The broker also lifted its target price from $3.20 to $4.20.

This implies potential capital growth of 13% over the next year.

Morgans said:

SRG has upgraded FY26 EBITDA guidance to the upper end of its $164-168m range (~$168m) and, unusually early, provided FY27 EBITDA guidance of $190-200m. This underlines the group's strong earnings visibility, which is arguably unparalleled in the services sector.

We forecast SRG reaches net cash in FY26 and, on that basis, expect it to resume acquisitions. We believe SRG may be able to continue to compound +20-30% EPS growth over the next few years as robust organic growth is supplemented by strategic acquisitive growth. 

Centuria Capital Group (ASX: CNI)

The Centuria Capital share price is $2.02, up 2.5% today and down 4.3% over six months.

Centuria Capital Group is a funds manager specialising in property investment and investment bonds.

Morgan Stanley renewed its buy rating on this ASX 200 real estate share on Tuesday.

The broker lifted its 12-month price target from $2.05 to $2.35.

This suggests a potential 16% upside ahead.

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Life360. The Motley Fool Australia has positions in and has recommended Life360. The Motley Fool Australia has recommended CSL, Flight Centre Travel Group, Gqg Partners, and Srg Global. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A woman stands in a field and raises her arms to welcome a golden sunset.
Gold

4 ASX 200 gold shares to buy: Experts

Experts explain their buy ratings following these miners' June quarter reports.

Read more »

Three balls at various places on a cycle.
Broker Notes

6 ASX uranium shares to buy ahead of yellow cake rising to US$200 per pound: experts

This broker tips 83% to 295% upside over 12 months for its 6 top ASX uranium share picks.

Read more »

A hipster-looking man with bushy beard and multiple arm tattoos sits on the floor against a sofa reading a tablet with his hand on his chin as though he is deep in thought.
Broker Notes

Buy, hold, sell: Capstone Copper, Lindsay Australia, Woodside shares

Let's take a look at three fresh buy, hold, and sell calls from the experts. 

Read more »

A man in a business suit scratches his head looking at a graph that started high then dips, then starts to go up again like a rollercoaster.
Broker Notes

Down 23% and 58%, should I buy TechnologyOne and Xero shares now?

A leading expert provides his forecasts for TechnologyOne and Xero shares.

Read more »

An analyst wearing a dark blue shirt and glasses sits at his computer with his chin resting on his hands.
Broker Notes

Buy, hold, sell: Ramsay Healthcare, Xero, Electro Optic Systems shares

Let's take a look at three fresh buy, hold, and sell calls from the experts. 

Read more »

ASX 300 share investors in suits running a race on an athletics track
Broker Notes

Why Macquarie shares are forecast to outpace ASX bank stocks like CBA and Westpac

A leading analyst expects Macquarie shares to keep outpacing the big four ASX banks, including CBA and Westpac.

Read more »

Buy, hold, and sell ratings written on signs on a wooden pole.
Broker Notes

Down 27%, are Boss Energy shares a buy, hold or sell?

A leading analyst delivers his outlook for Boss Energy’s beaten-down shares.

Read more »

a woman holds a cup to her ear and leans in with a wide mouthed expression on her face as though she is listening to interesting and perhaps surprising information.
Broker Notes

Buy, hold, sell: Dexus, Origin Energy, Magellan shares

Let's start the week with some fresh ratings from Dylan Evans of Catapult Wealth.

Read more »